Talk:Neonatal Diagnosis: Difference between revisions
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
==Cystic fibrosis newborn screening== | {{Talk Page}} | ||
==10 Most Recent== | |||
{{10 Most Recent}} | |||
===Neonatal Diagnosis=== | |||
<pubmed limit=5>Neonatal Diagnosis</pubmed> | |||
===Guthrie Test=== | |||
<pubmed limit=5>Guthrie Test</pubmed> | |||
==2013== | |||
==2012== | |||
==2011== | |||
==2010== | |||
===Cystic fibrosis newborn screening=== | |||
Com G. | Com G. | ||
J Ark Med Soc. 2010 Mar;106(9):210-2. Review. | J Ark Med Soc. 2010 Mar;106(9):210-2. Review. | ||
| Line 7: | Line 26: | ||
Cystic fibrosis (CF) is a life-threatening autosomal recessive disease and affects about 1 in 3500 newborns in the United States. In the last decade, advances to detect the disease include development of newborn screening. CF newborn screening is a complex process and diagnosing a newborn with CF sometimes can be challenging even for an expert. In this article, we briefly discuss the pathogenesis of cystic fibrosis followed by a discussion of the need to conduct newborn screening and the screening algorithm. Finally, healthcare providers are directed to contact information to learn more about diagnosing and treating cystic fibrosis in Arkansas. Cystic fibrosis is the result of a mutant gene located on chromosome 7; the gene product is named cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is located in the apical membranes of most of the cell lines and responsible for chloride ion conduction. In addition, CFTR influences the expression of several other gene products. | Cystic fibrosis (CF) is a life-threatening autosomal recessive disease and affects about 1 in 3500 newborns in the United States. In the last decade, advances to detect the disease include development of newborn screening. CF newborn screening is a complex process and diagnosing a newborn with CF sometimes can be challenging even for an expert. In this article, we briefly discuss the pathogenesis of cystic fibrosis followed by a discussion of the need to conduct newborn screening and the screening algorithm. Finally, healthcare providers are directed to contact information to learn more about diagnosing and treating cystic fibrosis in Arkansas. Cystic fibrosis is the result of a mutant gene located on chromosome 7; the gene product is named cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is located in the apical membranes of most of the cell lines and responsible for chloride ion conduction. In addition, CFTR influences the expression of several other gene products. | ||
Lung maturation: the survival miracle of very low birth weight infants | ===Lung maturation: the survival miracle of very low birth weight infants=== | ||
Jobe AH. | Jobe AH. | ||
Pediatr Neonatol. 2010 Feb;51(1):7-13. Review. | Pediatr Neonatol. 2010 Feb;51(1):7-13. Review. | ||
PMID: 20225532 | PMID: 20225532 | ||
Revision as of 08:10, 30 March 2013
| About Discussion Pages |
|---|
Glossary Links
Cite this page: Hill, M.A. (2024, April 24) Embryology Neonatal Diagnosis. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Talk:Neonatal_Diagnosis |
10 Most Recent
Note - This sub-heading shows an automated computer PubMed search using the listed sub-heading term. References appear in this list based upon the date of the actual page viewing. Therefore the list of references do not reflect any editorial selection of material based on content or relevance. In comparison, references listed on the content page and discussion page (under the publication year sub-headings) do include editorial selection based upon relevance and availability. (More? Pubmed Most Recent)
Neonatal Diagnosis
<pubmed limit=5>Neonatal Diagnosis</pubmed>
Guthrie Test
<pubmed limit=5>Guthrie Test</pubmed>
2013
2012
2011
2010
Cystic fibrosis newborn screening
Com G. J Ark Med Soc. 2010 Mar;106(9):210-2. Review. PMID: 20337169
Cystic fibrosis (CF) is a life-threatening autosomal recessive disease and affects about 1 in 3500 newborns in the United States. In the last decade, advances to detect the disease include development of newborn screening. CF newborn screening is a complex process and diagnosing a newborn with CF sometimes can be challenging even for an expert. In this article, we briefly discuss the pathogenesis of cystic fibrosis followed by a discussion of the need to conduct newborn screening and the screening algorithm. Finally, healthcare providers are directed to contact information to learn more about diagnosing and treating cystic fibrosis in Arkansas. Cystic fibrosis is the result of a mutant gene located on chromosome 7; the gene product is named cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is located in the apical membranes of most of the cell lines and responsible for chloride ion conduction. In addition, CFTR influences the expression of several other gene products.
Lung maturation: the survival miracle of very low birth weight infants
Jobe AH. Pediatr Neonatol. 2010 Feb;51(1):7-13. Review. PMID: 20225532
